David Grainger

Chief Scientific Advisor

London, England, United Kingdom

28 investments

David Grainger is a Chief Scientific Advisor at Rivus Pharmaceuticals based in London, England, United Kingdom. David Grainger has backed 28 companies, including Gadeta, SuperX and Critical Pressure. Investment focus areas include Health Care, Hospitals and Delivery Service.

Investment Focus

Hispanic / Latinx Founded

Hispanic / Latinx Led

Portfolio Companies (27)


1	Gadeta
2	SuperX
3	Critical Pressure
4	Impact Biomedicines
5	Inexia
6	Aura Biosciences
7	Janpix
8	Alderaan Biotechnology
9	ApcinteX
10	Yukin Therapeutics
11	Xenikos
12	Palladio Biosciences

Showing 1–12 of 27

Page 1 of 3

Access Full Contact Information

Get David Grainger's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

Portfolio

3-day free trial, cancel anytime

Raising a round? Run your numbers first

Free tools founders use before pitching investors like this one.

Runway calculatorHow long your cash lasts Burn rate calculatorMonthly spend, gross and net Funding goal calculatorHow much to raise Investor ROI calculatorWhat your investors earn Pitch deck template11 slides that close Fundraising playbookThe 7-step raise process